Carregant...
Profile of crizanlizumab and its potential in the prevention of pain crises in sickle cell disease: evidence to date
Sickle cell disease (SCD) is one of the most common inherited blood disorders globally. It is a grouping of autosomal recessive genetic disorders identified by a genetic mutation that replaces glutamic acid with valine at the sixth amino acid on the hemoglobin β-globin chain. Millions of people arou...
Guardat en:
| Publicat a: | J Blood Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6720158/ https://ncbi.nlm.nih.gov/pubmed/31507334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S191423 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|